Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621009 · ClinicalTrials.gov registry record · Phase 4
Bupropion SR Plus Counseling for Smoking Cessation
A Phase 4 study of Smoking and Tobacco Dependence, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 463
- Enrollment target
- 1
- Study location
NCT01621009 is a Phase 4 study of Smoking and Tobacco Dependence that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 463 participants, roughly in line with the 451-participant average among 123 other Smoking trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT01621009, a Phase 4 study of Smoking and Tobacco Dependence, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 463 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to determine if bupropion plus counseling was more effective than bupropion alone or counseling alone in helping smokers quit smoking.
Conditions Studied
Interventions
- DRUG Active bupropion + counseling
- DRUG Active bupropion, No counseling
- DRUG Placebo medication + counseling
- DRUG Placebo medication, No counseling
Study Locations (1)
Wisconsin
- UW Center for Tobacco Research and Intervention - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2001-01 |
| Est. Completion | 2003-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621009
The ClinicalTrials.gov registry entry for NCT01621009 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 463 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 451-participant average among 123 other Smoking trials with a reported enrollment target. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 4 interventions - of which Active bupropion + counseling is the first listed.
NCT01621009 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01621009 about?
NCT01621009 is a clinical study titled "Bupropion SR Plus Counseling for Smoking Cessation". The purpose of this study was to determine if bupropion plus counseling was more effective than bupropion alone or counseling alone in helping smokers quit smoking.
What is the current status of trial NCT01621009?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 463 participants. The study started on 2001-01. Estimated completion is 2003-10.
What conditions does trial NCT01621009 study?
This clinical trial studies the following conditions: Smoking, Tobacco Dependence.
What interventions are being tested in trial NCT01621009?
The interventions under investigation include: Active bupropion + counseling (DRUG), Active bupropion, No counseling (DRUG), Placebo medication + counseling (DRUG), Placebo medication, No counseling (DRUG).
Who is sponsoring clinical trial NCT01621009?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01621009 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Identifying Treatments to Motivate Smokers to Quit
COMPLETED · Phase 4
-
Smoking Tobacco and Drinking Study
COMPLETED · Phase 4
-
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
COMPLETED · Phase 4
-
Long-term Varenicline Treatment for Smoking Cessation
COMPLETED · Phase 4
-
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.